Review Article
The Potential Therapeutic Role of Mesenchymal Stem Cells-Derived Exosomes in Osteoradionecrosis
Table 1
MSC exosomes promote angiogenesis through various signaling pathways.
| Exosomes | Pathway/key molecule | Function | Experiment type | Reference |
| MSC exosomes derived from overexpressing HIF-1α | Jagged 1/Notch | Enhanced angiogenesis and capillary-like tube formation | In vitro | [111] | Exosomes derived from DMOG-stimulated human bone marrow MSCs | Akt/mTOR | Promoted angiogenesis in the critical-sized calvarial defect rat model | In vivo | [112] | iPS-MSC-Exos | PI3K/Akt | Enhanced the proliferation, migration, and tube-forming capacities of endothelial cells | In vitro | [113] | Exosomes from hiPSC-MSC | — | Enhanced angiogenesis and osteogenesis under osteoporotic conditions | In vivo | [114] | CD63+ exosomes derived from bone marrow MSCs | Wnt3 protein | Enhanced endothelial angiogenesis | In vitro | [115] | Exosomes released from hP-MSCs by NO stimulation | VEGF and miR-126 | Enhanced the angiogenic effects of HUVECs | In vitro | [116] |
|
|